Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 61

1.

The cutaneous manifestations are significantly related to cerebrovascular in a Serbian cohort of patients with Hughes syndrome.

Stojanovich L, Djokovic A, Stanisavljevic N, Zdravkovic M.

Lupus. 2018 Jan 1:961203317751065. doi: 10.1177/0961203317751065. [Epub ahead of print]

PMID:
29301476
2.

Abdominal pain in patient with antiphospholipid syndrome-the role of MDCT angiography on visceral blood vessels.

Saponjski J, Stojanovich L, Saponjski J, Mirilovic M, Saponjski D.

Immunol Res. 2017 Dec;65(6):1150-1155. doi: 10.1007/s12026-017-8968-1.

PMID:
29134567
3.

Effects of sustained i.c.v. infusion of lupus CSF and autoantibodies on behavioral phenotype and neuronal calcium signaling.

Kapadia M, Bijelić D, Zhao H, Ma D, Stojanovich L, Milošević M, Andjus P, Šakić B.

Acta Neuropathol Commun. 2017 Sep 7;5(1):70. doi: 10.1186/s40478-017-0473-1.

4.

The interaction between anti-Ro/SSA and anti-La/SSB autoantibodies and anti-infectious antibodies in a wide spectrum of auto-immune diseases: another angle of the autoimmune mosaic.

Agmon-Levin N, Dagan A, Peri Y, Anaya JM, Selmi C, Tincani A, Bizzaro N, Stojanovich L, Damoiseaux J, Cohen Tervaert JW, Mosca M, Cervera R, Shoenfeld Y.

Clin Exp Rheumatol. 2017 Nov-Dec;35(6):929-935. Epub 2017 Jul 6.

PMID:
28770708
5.

Are the cutaneous manifestations in patients with primary antiphospholipid syndrome a marker for predicting lung manifestations?

Kontic M, Stojanovich L, Mijailović-Ivković M, Velinović M, Srnka J, Zdravkovic M.

Clin Exp Rheumatol. 2017 Jul 17. [Epub ahead of print]

PMID:
28770705
6.

The role of MSCT angiography in early detection of lower limb arterial lesions in patients with antiphospholipid syndrome.

Saponjski J, Stojanovich L, Petrovic J, Saponjski D.

Immunol Res. 2017 Apr;65(2):482-486. doi: 10.1007/s12026-016-8887-6.

PMID:
28124228
7.

Lipid peroxidation as risk factor for endothelial dysfunction in antiphospholipid syndrome patients.

Stanisavljevic N, Stojanovich L, Marisavljevic D, Djokovic A, Dopsaj V, Kotur-Stevuljevic J, Martinovic J, Memon L, Radovanovic S, Todic B, Lisulov D.

Clin Rheumatol. 2016 Oct;35(10):2485-93. doi: 10.1007/s10067-016-3369-8. Epub 2016 Aug 25.

PMID:
27562033
8.

Physical Activity Program Is Helpful for Improving Quality of Life in Patients with Systemic Lupus Erythematosus.

Bogdanovic G, Stojanovich L, Djokovic A, Stanisavljevic N.

Tohoku J Exp Med. 2015 Nov;237(3):193-9. doi: 10.1620/tjem.237.193.

9.

Factor H Autoantibodies in Patients with Antiphospholipid Syndrome and Thrombosis.

Foltyn Zadura A, Memon AA, Stojanovich L, Perricone C, Conti F, Valesini G, Bogdanovic G, Hillarp A, Shoenfeld Y, Sundquist J, Leffler J, Svensson PJ, Trouw LA, Blom AM.

J Rheumatol. 2015 Oct;42(10):1786-93. doi: 10.3899/jrheum.150185. Epub 2015 Aug 15.

PMID:
26276971
10.
11.

Erratum to: Immunoreactivity and avidity of IgG anti-β2-glycoprotein I antibodies from patients with autoimmune diseases to different peptide clusters of β2-glycoprotein I.

Artenjak A, Locatelli I, Brelih H, Simonič DM, Ulcova-Gallova Z, Swadzba J, Musial J, Iwaniec T, Stojanovich L, Conti F, Valesini G, Avčin T, Cohen Tervaert JW, Shoenfeld Y, Blank M, Ambrožič A, Sodin-Semrl S, Božič B, Čučnik S.

Immunol Res. 2015 Feb;61(1-2):45. doi: 10.1007/s12026-014-8610-4. No abstract available.

PMID:
25480741
12.

Immunoreactivity and avidity of IgG anti-β2-glycoprotein I antibodies from patients with autoimmune diseases to different peptide clusters of β2-glycoprotein I.

Artenjak A, Locatelli I, Brelih H, Simonič DM, Ulcova-Gallova Z, Swadzba J, Musial J, Iwaniec T, Stojanovich L, Conti F, Valesini G, Avčin T, Cohen Tervaert JW, Shoenfeld Y, Blank M, Ambrožič A, Sodin-Semrl S, Božič B, Čučnik S.

Immunol Res. 2015 Feb;61(1-2):35-44. doi: 10.1007/s12026-014-8578-0. Erratum in: Immunol Res. 2015 Feb;61(1-2):45.

PMID:
25395339
13.

Association between cardiac manifestations and antiphospholipid antibody type and level in a cohort of Serbian patients with primary and secondary antiphospholipid syndrome.

Djokovic A, Stojanovich L, Kontic M, Stanisavljevic N, Radovanovic S, Marisavljevic D.

Isr Med Assoc J. 2014 Mar;16(3):162-7.

14.

Tomography and blood vessels in Hughes syndrome.

Stojanovich L, Djokovic A.

Lupus. 2014 Apr;23(4):337-41. doi: 10.1177/0961203313520061. Epub 2014 Jan 16. Review.

PMID:
24436444
15.

Degradation of neutrophil extracellular traps is decreased in patients with antiphospholipid syndrome.

Leffler J, Stojanovich L, Shoenfeld Y, Bogdanovic G, Hesselstrand R, Blom AM.

Clin Exp Rheumatol. 2014 Jan-Feb;32(1):66-70. Epub 2013 Dec 2.

PMID:
24295292
16.

Does the presence of secondary antiphospholipid syndrome in patients with systemic lupus erythematodes accelerate carotid arteries intima-media thickness changes?

Djokovic A, Stojanovich Lj, Stanisavljevic N, Bisenic V, Radovanovic S, Soldatovic I, Simic DV.

Rheumatol Int. 2014 Mar;34(3):321-7. Epub 2013 Nov 15.

PMID:
24232505
17.

Pediatric catastrophic antiphospholipid syndrome: descriptive analysis of 45 patients from the "CAPS Registry".

Berman H, Rodríguez-Pintó I, Cervera R, Gregory S, de Meis E, Rodrigues CE, Aikawa NE, de Carvalho JF, Springer J, Niedzwiecki M, Espinosa G; Catastrophic Registry Project Group (European Forum on Antiphospholipid Antibodies).

Autoimmun Rev. 2014 Feb;13(2):157-62. doi: 10.1016/j.autrev.2013.10.004. Epub 2013 Oct 19.

PMID:
24145009
18.

Ferritin in the antiphospholipid syndrome and its catastrophic variant (cAPS).

Agmon-Levin N, Rosário C, Katz BS, Zandman-Goddard G, Meroni P, Cervera R, Stojanovich L, Blank M, Pierangeli S, Praprotnik S, Meis Ed, Seguro LP, Ruffatti A, Pengo V, Tincani A, Doria A, Shoenfeld Y.

Lupus. 2013 Nov;22(13):1327-35. doi: 10.1177/0961203313504633. Epub 2013 Sep 13.

PMID:
24036580
19.

Association between non-thrombotic neurological and cardiac manifestations in patients with antiphospholipid syndrome.

Stojanovich L, Kontic M, Smiljanic D, Djokovic A, Stamenkovic B, Marisavljevic D.

Clin Exp Rheumatol. 2013 Sep-Oct;31(5):756-60. Epub 2013 Jul 30.

PMID:
23899875
20.

Rituximab use in the catastrophic antiphospholipid syndrome: descriptive analysis of the CAPS registry patients receiving rituximab.

Berman H, Rodríguez-Pintó I, Cervera R, Morel N, Costedoat-Chalumeau N, Erkan D, Shoenfeld Y, Espinosa G; Catastrophic Antiphospholipid Syndrome (CAPS) Registry Project Group (European Forum on Antiphospholipid Antibodies).

Autoimmun Rev. 2013 Sep;12(11):1085-90. doi: 10.1016/j.autrev.2013.05.004. Epub 2013 Jun 15.

PMID:
23777822

Supplemental Content

Loading ...
Support Center